View printer-friendly version
« Back
June 04, 2012 2:38 p.m.
Teva to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference

JERUSALEM--(BUSINESS WIRE)--Jun. 4, 2012-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Goldman Sachs 33rd Annual Global Healthcare Conference in California. Dr. Jeremy Levin, President & CEO, will present on Tuesday, June 5, 2012.

What:

 

Teva Presentation at the Goldman Sachs 33rd Annual Global Healthcare Conference

Who:

Dr. Jeremy Levin, President & CEO

When:

Tuesday, June 5, 2012 at 8:40 AM PT

Where:

http://cc.talkpoint.com/gold006/060512a_lr/?entity=6_SQWKIX7

How:

Live over the Internet – log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $18.3 billion in net revenues in 2011.

Source: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.
IR:
United States
Kevin C. Mannix, 215-591-8912
or
Israel
Tomer Amitai, 972 (3) 926-7656
or
PR:
United States
Denise Bradley, 215-591-8974
or
Israel
Shir Altay-Hagoel, 972 (3) 926-7590